20-9307875-G-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The ENST00000378473.9(PLCB4):c.61G>A(p.Ala21Thr) variant causes a missense change. The variant allele was found at a frequency of 0.633 in 1,557,610 control chromosomes in the GnomAD database, including 323,537 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A21E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000378473.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLCB4 | NM_001377142.1 | c.61G>A | p.Ala21Thr | missense_variant | 4/40 | ENST00000378473.9 | NP_001364071.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLCB4 | ENST00000378473.9 | c.61G>A | p.Ala21Thr | missense_variant | 4/40 | 1 | NM_001377142.1 | ENSP00000367734 |
Frequencies
GnomAD3 genomes AF: 0.516 AC: 78385AN: 151814Hom.: 23566 Cov.: 31
GnomAD3 exomes AF: 0.596 AC: 147393AN: 247122Hom.: 46298 AF XY: 0.610 AC XY: 81429AN XY: 133598
GnomAD4 exome AF: 0.646 AC: 907575AN: 1405678Hom.: 299964 Cov.: 23 AF XY: 0.648 AC XY: 454891AN XY: 702170
GnomAD4 genome AF: 0.516 AC: 78393AN: 151932Hom.: 23573 Cov.: 31 AF XY: 0.512 AC XY: 38046AN XY: 74250
ClinVar
Submissions by phenotype
Auriculocondylar syndrome 2 Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at